ARCHIVES

Xgeva Significantly Increases Bone Metastasis-Free Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

Henry Neil, Natcher’s right arm, Back In The Job

March 25, 1988

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011